Value of positron emission tomography for lung cancer staging
- 1 February 2002
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 28 (1) , 55-62
- https://doi.org/10.1053/ejso.2001.1144
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Usefulness of positron emission tomography imaging in the management of lung cancerCurrent Opinion in Pulmonary Medicine, 1999
- Improvement of Non-Small-Cell Lung Cancer Staging by Means of Positron Emission TomographyThe Thoracic and Cardiovascular Surgeon, 1999
- Positron Emission Tomography in Lung CancerThe Annals of Thoracic Surgery, 1998
- Mediastinal lymph node staging of non-small-cell lung cancer: A prospective comparison of computed tomography and positron emission tomographyThe Journal of Thoracic and Cardiovascular Surgery, 1996
- Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET)The Journal of Thoracic and Cardiovascular Surgery, 1995
- Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancerThe Lancet, 1994
- Lung Cancer StagingChest, 1991
- Clinical Staging of Patients with Non-small Cell Lung CancerChest, 1990
- Glucose utilizationin vivo by human pulmonary neoplasmsCancer, 1987
- On the Origin of Cancer CellsScience, 1956